Tubeless Intersegmentectomy Plane Identification With Fluorography
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: inflation- deflation line combined with ICG fluorography.
- Who it may be relevant to
- Registry conditions: Operation Time, Postoperative Complications. Basic parameters: 18 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Tubeless Intersegmentectomy Plane Identification With Inflation- Deflation Line Combined With Fluorography
Overview
Background: We aimed to evaluate the combination of inflation- deflation method and fluorography with the ICG injection in the tubeless minimally invasive segmentectomy (no intubation, VATS or Robotic). Methods: A one- armed, prospective randomized controlled study was designed. The intersegmental plane was not so clear during the tubeless minimally invasive segmentectomy, and the presentation of the plane sometimes cost more time. This study will evaluate consecutive patients with the combination of inflation- deflation method and fluorography with the ICG injection.
Interventions
- Procedure inflation- deflation line combined with ICG fluorography
Identification of the intersegmental plane using inflation- deflation line combined with ICG fluorography under the status of tubeless
Primary outcome measures
- time of description and management of the intersegmental plane [Time frame: during surgery]
- perioperative complication rate [Time frame: within 7 days after surgery]
- incisal margin of the tumor [Time frame: during surgery]
Secondary outcome measures (1)
- disease- free survival [Time frame: within 5 years after surgery]
Eligibility criteria
Inclusion criteria
- cardio- pulmonary function can tolerate the minimally invasive surgery (including VATS and robotic surgery);
- benign pulmonary lesion considering for segmentectomy;
- ≤2cm pulmonary adenocarcinoma with ground- glass components, considering for segmentectomy.
Exclusion criteria
- cardio- pulmonary function can not tolerate the minimally invasive surgery (including VATS and robotic surgery);
- segmentectomy is not considered as the surgery plan.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
China · 1 center
- Yunpeng Zhao — Jinan
Identifiers
NCT: NCT05479825 · Tubeless Intersegmental ICG